Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
69,292,924
-
Share change
-
-6,324,261
-
Total reported value
-
$422,665,502
-
Put/Call ratio
-
36%
-
Price per share
-
$6.10
-
Number of holders
-
127
-
Value change
-
-$92,941,856
-
Number of buys
-
63
-
Number of sells
-
66
Institutional Holders of IMMUNOGEN INC - COMMON STOCK (IMGN) as of Q4 2014
As of 31 Dec 2014,
IMMUNOGEN INC - COMMON STOCK (IMGN) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,292,924 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Clearbridge Investments, LLC, FMR LLC, VANGUARD GROUP INC, BB Biotech AG, BlackRock Fund Advisors, State Street Corp, BlackRock Institutional Trust Company, N.A., MILLENNIUM MANAGEMENT LLC, and NORGES BANK.
This page lists
127
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.